Drug profile · INN
milrinone lactate
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
milrinone lactate (MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER) is a phosphodiesterase 3a inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — milrinone lactate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 6
- Programs
- 1
- Data quality
- 0.84
Quick answer
milrinone lactate (MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER) is a phosphodiesterase 3a inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Phosphodiesterase 3A inhibitor
Primary target: cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 10188135
Method for inducing satiety
granted -
US 10130607
Methods of reducing blood lactate concentration
granted -
US 10105344
Methods of reducing blood lactate concentration
granted -
US 9198453
Methods of reducing blood lactate concentration
granted -
US 9089156
Reducing muscle soreness with glucosamine compositions
granted -
US 7993690
Carbohydrate and electrolyte replacement composition
granted
Frequently asked questions
What is milrinone lactate?
milrinone lactate (MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER) is a phosphodiesterase 3a inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for milrinone lactate?
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER is a marketed brand name for milrinone lactate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of milrinone lactate?
milrinone lactate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.